GLP Vs. GCP Vs. Enago Academy, "Understanding the Regulations: GLP vs GCP vs GMP." Enago Academy. The quality of data or goods resulting from scientific research must be held to high standards. Good Laboratory Practice (GLP) regulates the processes and conditions under which clinical and non-clinical research is conducted. GLP also governs how these research facilities should be maintained. Good Clinical Practice (GCP) guidelines are dictated by the International Conference on Harmonization (ICH). The ICH GCP covers things such as the study design, methodology, and data reporting related to clinical trials. Finally, Good Manufacturing Practice (GMP) regulates the design, monitoring, and control of manufacturing processes and facilities. GMP compliance, for example, ensures the identity, strength, quality, and purity of drug products. United States, irrespective of where the products were developed or manufactured. The FDA should conduct at least one routine inspection to determine if a study is GLP compliant at least once every other year. They may also conduct for-cause inspections if there is a reason to believe that a study site is failing to comply with GLP regulations.

GCP, on the other hand, is intended to ensure the safety of trial participants. It is important that there is a system in place to report all adverse events (AE) or severe adverse events (SAE). GCP also governs data collection during clinical trials. It is important that the data generated in the trial is recorded in compliance with GCP regulations to ensure its integrity. The sponsor must also set the level of the GCP monitoring process. The monitoring process itself must be documented to show that the study meets GCP standards before, during, and after the clinical trial. GMP regulations, as the name suggests, exist to control the quality of manufactured goods. GMP requirements are flexible to give each manufacturer the ability to choose how they implement the necessary controls. All GMP protocols rely on rigorously tested scientific principles. GMP also requires strict quality management, use of good quality raw materials, identifying deviations in product quality, and using reliable testing laboratories.

GMP ensures consistent adherence to the quality standards required if the final product is effectively and reliably used. GMP compliant. If a company does not abide by GMP and therefore produces a defective drug, a recall may be issued. The FDA cannot force a recall but it can warn the public of the danger and seize any defective drugs present in the marketplace. The FDA may also acquire a legal injunction to address GMP violations. GLP, GCP, and GMP regulations all exist to ensure that the processes they govern are held to high scientific and ethical standards. GLP regulations are mostly concerned with good study protocols and record keeping. These safeguard the integrity of the findings. GCP guidelines ensure that the safety of clinical trial participants remains of utmost importance. These guidelines are set by the ICH. Finally, GMP guidelines ensure that the manufacturing process is of a high standard with the appropriate quality control and quality assurance measures in place.

In these ways, all three sets of regulations protect consumers, patients, test subjects, and researchers. Study Director appointed by testing facility management. The Study Sponsor is responsible. In a case where a study is conducted by a team of individuals, the Principal Investigator is responsible. No Study Director is assigned. No single point of contact is required. Quality Assurance Unit inspects critical phases of each study and periodically inspects the facility. Quality control system is not involved. Quality Control Unit is responsible to approve or reject all procedures and aspects of testing/manufacturing. Testing Facility Management is responsible for designating a Study Director. The Study Director ensures that the facility, personnel, equipment, etc. is available and complies with the GLPs. Study Sponsors are responsible for ensuring that a GCP study is adequately supervised. Whereas, Principal Investigators ensure that participating Sub-Investigators have adequate training and experience to assist in the study. Supervisors should have proper training.

Responsibilities should be in written procedures and followed. Open-ended determination of product performance, often for submission to the EPA or FDA for pre-market approval. Studies that involve the participation of human subjects where data is intended to be submitted to regulatory authorities. Determination of whether or not the product/sample has met manufacturing specifications. Design and construction must be suitable to the type of testing conducted. The testing facility must have adequate facilities available for the foreseen duration of the study. Design construction must be suitable to the type of testing conducted. Equipment must be appropriate, maintained, calibrated, and the state of equipment documented to provide study reconstructability. Equipment must be appropriate to safely conduct the study. Equipment must be qualified for accuracy, sensitivity, specificity, MedicGLP Website and reproducibility in manufacturing processes. SOPs must be drafted by a qualified personnel, approved by Testing Facility Management. Drafted by a qualified personnel, and may be written by the Study Sponsor, Contract Research Organization, or Testing Site.